News

The AHEAD recommendations focus on achieving disease control in atopic dermatitis by allowing patients to identify key symptoms and clinicians to select matching outcomes to guide therapy, aiming for a higher standard of care.

The study found that after 4 weeks of using the action plan, AD severity decreased markedly, with many patients achieving mild AD status.

The findings support the idea that Botox can enhance emotional well-being and self-confidence, although it did not notably impact the quality of life.

Bullous pemphigoid in youth is rare and can be missed due to negative BP180 ELISA results, complicating timely diagnosis in children.

Approximately 8.8% of patients achieved complete response a year after onset of diphenylcyclopropenone therapy.

Biologics work by inhibiting inflammatory cytokines, but a small percentage of patients may experience “paradoxical psoriasis.”

At the conclusion of their roundtable event, Rocco Serrao, MD, FAAD; Latanya Benjamin, MD, FAAD; and Anthony Nuara, MD, PhD, discuss final considerations for tailoring vitiligo treatment plans.

A recent study found after 6 months, CGF therapy resulted in a sustained increase in terminal hair density without significant adverse events.

Researchers tailored screening and surveillance schedules to individual risk of patients.

Rates of infection did not correlate with disease severity, however.

Keep up with the latest headlines in dermatology from the past week, including the presence of toxic "forever chemicals" in artificial turf, commercial availability of apremilast in the US, and more.

In case you missed it, this week we had news about Pelage's novel PP405 in phase 2a for androgenetic alopecia, the availability of apremilast in the US for pediatric psoriasis, higher patient adherence with pre-filled risankizumab pens, and more.

Acne vulgaris has been reported as an adverse effect of GLP-1 receptor agonists by some patients.

A recent study found prefilled pens with concealed needles showed promise in reducing injection-related anxiety and improving patient adherence.

A comprehensive analysis of 71 studies revealed the highest lesion clearance and recurrence rates among individuals who had undergone surgery.

Autologous fat grafting may be able to treat alopecia by controlling inflammation, enhancing symptoms, and boosting hair density.

A recent study confirmed that collagen peptides effectively counteract age-related skin issues such as reduced density and increased dryness.

Researchers identified mistrust, social stigma, and language barriers as major obstacles for ethnic minorities in skin research.

After treatment with the topical JAK inhibitor, researchers reported significant improvement of lesional skin.

In a review, researchers reported that ethnicity plays a role in outcomes, presentations, and more for individuals with systemic sclerosis.

Anthony Nuara, MD, PhD, reviewed a case study of a 32-year-old professional makeup artist who was concerned about her depigmented patches affecting her livelihood.

The National Psoriasis Foundation's new report provides an overview of the health impacts of psoriasis, revealing significant issues in care and outcomes.

This week’s collection of the latest dermatologic studies includes the prevalence of vulvar dermatoses among ethnically diverse patients, the adaptation of the Mackie melanoma risk stratification tool into a tablet-based patient questionnaire, siblings diagnosed with hereditary sensory and autonomic neuropathy, and more.

The study found 95.8% of ocular AEs occurred in AD patients, while SA patients reported only 4.2% of these events.

Over 6 weeks, most saw patients saw improvement, with daily medication linked to better quality of life and reduced skin picking.

Researchers say promising study findings warrant further exploration of EID's potential on a larger scale.

A review found repeated laser treatments show cumulative benefits, including improved collagen density and skin elasticity over time.

At the correct dosage, researchers noted non-significant changes in BMI or metabolic syndrome markers among patients.

The availability is notable as it introduces the first oral treatment option for young psoriasis patients.

Latanya Benjamin, MD, FAAD, reviewed a case study of a 35-year-old woman with a 10-year history of vitiligo and concomitant atopic dermatitis